Clinical Trial Update: Efficacy and Safety of Tocotrienols in CADASIL [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing the efficacy and safety of tocotrienols in CADASIL has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy

Drugs mentioned

• Tocotrienols (tocotrienols)

Snippet

Sponsor: Hovid Berhad | Conditions: Cadasil | Phase 2 | Status: COMPLETED